BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 38575994)

  • 1. RNA m6A methylation regulators in ovarian cancer.
    Guo J; Zheng J; Zhang H; Tong J
    Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of m6A methylation modification in ovarian cancer.
    Chang LL; Xu XQ; Liu XL; Guo QQ; Fan YN; He BX; Zhang WZ
    Cancer Cell Int; 2021 Dec; 21(1):663. PubMed ID: 34895230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginger inhibits the invasion of ovarian cancer cells SKOV3 through CLDN7, CLDN11 and CD274 m6A methylation modifications.
    Zhang X; Zhang H; Zhu L; Xia L
    BMC Complement Med Ther; 2024 Apr; 24(1):145. PubMed ID: 38575994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells.
    Xie Y; Wang L; Luo Y; Chen H; Yang Y; Shen Q; Cao G
    Biotechnol Genet Eng Rev; 2023 Jan; ():1-15. PubMed ID: 36703541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
    Wu J; Wang X; Li X
    Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of METTL14 in epithelial ovarian cancer and the effect on cell proliferation, invasion and migration of A2780 and SKOV3 cells].
    Wei YS; Yao DS; Li L; Lu Y; Yang XM; Zhang WG
    Zhonghua Fu Chan Ke Za Zhi; 2022 Jan; 57(1):46-56. PubMed ID: 35090245
    [No Abstract]   [Full Text] [Related]  

  • 7. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
    Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon architecture controls mRNA m
    He PC; Wei J; Dou X; Harada BT; Zhang Z; Ge R; Liu C; Zhang LS; Yu X; Wang S; Lyu R; Zou Z; Chen M; He C
    Science; 2023 Feb; 379(6633):677-682. PubMed ID: 36705538
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Humantenine on mRNA m6A Modification and Expression in Human Colon Cancer Cell Line HCT116.
    Wu Y; Chen X; Bao W; Hong X; Li C; Lu J; Zhang D; Zhu A
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Shen M; Guo M; Li Y; Wang Y; Qiu Y; Shao J; Zhang F; Xu X; Yin G; Wang S; Chen A; Zhang Z; Zheng S
    Free Radic Biol Med; 2022 Mar; 182():246-259. PubMed ID: 35248719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of m6A RNA methylation in cancer metabolism.
    An Y; Duan H
    Mol Cancer; 2022 Jan; 21(1):14. PubMed ID: 35022030
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.